Early research (Phase 1)Ended earlyNCT04656275
What this trial is testing
A Study in Patients With Non-cystic Fibrosis Bronchiectasis to Test How Well Different Doses of BI 1323495 Are Tolerated and How BI 1323495 Affects Biomarkers of Inflammation
Who this might be right for
Non-cystic Fibrosis Bronchiectasis
Boehringer Ingelheim 7